BioCentury
ARTICLE | Top Story

Synsorb misses Phase III end point

July 12, 2000 7:00 AM UTC

Synsorb (TSE:SYB; SYBB) announced after market close that an interim analysis of its Phase III trial of 526 children receiving Synsorb Pk, an oligosaccharide complex to prevent Hemolytic Uremic Syndro...